Eduardo Asín-Prieto
6PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 27, 2025
CYP3A Genotype Is Associated With Variability in the Exposure and Clearance of the Novel Oncogenic Transcription Inhibitor Lurbinectedin.Rubin Lubomirov, Laura Pérez-Ramos, Salvador Fudio
|Jan 08, 2025
Description and Modeling of Relevant Demographic and Laboratory Variables in a Large Oncology Cohort to Generate Virtual Populations.Laura Pérez-Ramos, Laura Ibarra-Gómez, Rubin Lubomirov
|Oct 23, 2021
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function.Idoia Bilbao-Meseguer, Helena Barrasa, Eduardo Asín-Prieto
|May 06, 2020
Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy.Itziar Irurzun-Arana, Eduardo Asín-Prieto, Salvador Martín-Algarra
|Dec 12, 2019
A Quantitative Systems Pharmacology Model for the Key Interleukins Involved in Crohn's Disease.Violeta Balbas-Martinez, Eduardo Asin-Prieto, Zinnia P Parra-Guillen
|Mar 28, 2018
The Long Neglected Player: Modeling Tumor Uptake to Guide Optimal Dosing.Leire Ruiz-Cerdá, Eduardo Asín-Prieto, Zinnia P Parra-Guillen
Pageof 1
Frequent Collaborators
2 joint publications
Zinnia P Parra-Guillen
2 joint publications
Rubin Lubomirov
2 joint publications
Salvador Fudio
1 joint publications
Violeta Balbas-Martinez
1 joint publications
Itziar Irurzun-Arana
1 joint publications
Idoia Bilbao-Meseguer
1 joint publications
Helena Barrasa
1 joint publications
Ana Alarcia-Lacalle
1 joint publications
Alicia Rodríguez-Gascón
1 joint publications
María Ángeles Solinís
